Mesothelioma Latest Advances

Find the Latest Research About Mesothelioma

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18700 publications

Comment on Roberts at al: Historical cosmetic talc consumption and incidence of mesothelioma in the United States. International Journal of Environmental Health Research, 35:4, 972-980.

Comment on Roberts at al: Historical cosmetic talc consumption and incidence of mesothelioma in the United States. International Journal of Environmental Health Research, 35:4, 972-980.

Journal: International journal of environmental health research
Published: January 20, 2026

Mesothelioma Contrast Pharmacokinetics: A Feasibility Trial of the Use of Pharmacokinetic Analysis in Small-Volume Pleural Malignancy.

Mesothelioma Contrast Pharmacokinetics: A Feasibility Trial of the Use of Pharmacokinetic Analysis in Small-Volume Pleural Malignancy.

Journal: Radiology. Cardiothoracic imaging
Published: January 15, 2026

Artificial Intelligence in Pleural Diseases: Current Applications and Next Steps.

Artificial Intelligence in Pleural Diseases: Current Applications and Next Steps.

Journal: Thoracic research and practice
Published: January 15, 2026

Histiocytosis X discovered after chemotherapy treatment for mesothelioma

Histiocytosis X discovered after chemotherapy treatment for mesothelioma

Journal: Revue medicale de Liege
Published: January 15, 2026

Is formalin-fixed paraffin embedded tissue good enough for studies of transmission electron microscopy of tumors? a comparative study with wet tissue.

Is formalin-fixed paraffin embedded tissue good enough for studies of transmission electron microscopy of tumors? a comparative study with wet tissue.

Journal: Ultrastructural pathology
Published: January 05, 2026

Urinary Metabolites and Survival in Malignant Mesothelioma.

Urinary Metabolites and Survival in Malignant Mesothelioma.

Journal: medRxiv : the preprint server for health sciences
Published: December 31, 2025

First-in-class YAP/TEAD Inhibitor Shows Promise in Hippo-driven Mesothelioma.

First-in-class YAP/TEAD Inhibitor Shows Promise in Hippo-driven Mesothelioma.

Journal: Cancer discovery
Published: December 22, 2025

High Frequency and Unique Subtypes of Meningioma in Patients with BAP1 Tumor Predisposition Syndrome.

High Frequency and Unique Subtypes of Meningioma in Patients with BAP1 Tumor Predisposition Syndrome.

Journal: medRxiv : the preprint server for health sciences
Published: December 18, 2025

Rethinking 'extreme' cytoreductive surgery in malignant peritoneal mesothelioma.

Rethinking 'extreme' cytoreductive surgery in malignant peritoneal mesothelioma.

Journal: Acta chirurgica Belgica
Published: December 13, 2025

Rucaparib in refractory pleural mesothelioma harboring somatic pathogenic BRCA1 and BRCA2 mutation. A report of two cases.

Rucaparib in refractory pleural mesothelioma harboring somatic pathogenic BRCA1 and BRCA2 mutation. A report of two cases.

Journal: Lung cancer management
Published: December 12, 2025

Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.

Correction to: De novo pyrimidine synthesis is a collateral metabolic vulnerability in NF2-deficient mesothelioma.

Journal: EMBO molecular medicine
Published: December 11, 2025

Select updates in the pathology of kidney, testis, and penile cancer for 2026: Including FLCN-mutated (kidney) tumors, paratesticular mesothelial tumors, and TP53/HPV status in penile squamous cell carcinoma.

Select updates in the pathology of kidney, testis, and penile cancer for 2026: Including FLCN-mutated (kidney) tumors, paratesticular mesothelial tumors, and TP53/HPV status in penile squamous cell carcinoma.

Journal: Human pathology
Published: December 09, 2025
Showing 1-12 of 18,700

Last Updated: 02/24/2026